{"id":"W2044133019","doi":"10.3816/cbc.2010.n.011","title":"A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Epirubicin; Trastuzumab; Breast cancer; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Cyclophosphamide; Clinical endpoint; Metastatic breast cancer; Febrile neutropenia; Anthracycline; Gastroenterology; Neutropenia; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001447224,0.001792932,0.002417215,0.0005306274,0.0005669492,0.001036254,0.0009788376,0.001343533,0.004150128],"category_scores_gemma":[0.0009165433,0.0007955207,0.0008639873,0.00060355,0.00163853,0.001206424,0.0003681653,0.003407311,0.0009835094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001218705,"about_ca_system_score_gemma":0.001892697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002379125,"about_ca_topic_score_gemma":0.005784775,"domain_scores_codex":[0.9994206,0.0002766189,0.00002267888,0.0000954295,0.00004350022,0.0001411558],"domain_scores_gemma":[0.99925,0.0001518311,0.0001128132,0.0001138129,0.00003549396,0.000336003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7957793,0.1039086,0.001489823,0.0004815229,0.0006338509,0.0001391934,0.0002813928,0.002588047,0.043682,0.0003431176,0.002291245,0.04838184],"study_design_scores_gemma":[0.3963804,0.5904677,0.003478618,0.00002403345,0.0003226273,0.0001200966,0.00009274045,0.000840048,0.006285699,0.00016681,0.001790609,0.00003069681],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941348,0.001090784,0.0005224464,0.0005049424,0.0002431338,0.001494711,0.0003254399,0.0000774993,0.001606154],"genre_scores_gemma":[0.9894109,0.001601096,0.001476223,0.0005345598,0.0002077315,0.002369581,0.0008109087,0.00004716891,0.003541784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004150128,"threshold_uncertainty_score":0.01388353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01581447337146425,"score_gpt":0.3545481122868749,"score_spread":0.3387336389154106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}